Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Asian Pac J Cancer Prev ; 13(9): 4335-9, 2012.
Article in English | MEDLINE | ID: mdl-23167339

ABSTRACT

BACKGROUND: Whether sirolimus is useful in the prevention of non-melanoma skin cancer (NMSC) remains unclear and we therefore performed this meta-analysis of randomized controlled trials to test the hypothesis that Sirolimus-based immunosuppression is associated with a decrease in NMSC. METHODS: The main outcomes were NMSC, squamous-cell carcinoma and basal-cell carcinoma. The pooled risk ratio (RR) with its 95% confidence interval (95%CI) were used to assess the effects. RESULTS: 5 randomized trials involving a total of 1499 patients receiving kidney transplantation were included. Patients undergoing Sirolimus-based immunosuppression had much lower risk of NMSC (RR = 0.49, 95%CI 0.32-0.76, P = 0.001). Subgroup analyses by tumor type showed that Sirolimus-based immunosuppression significantly decreased risk of both squamous-cell carcinoma (RR = 0.58, 95%CI 0.43-0.78, P < 0.001) and basal-cell carcinoma (RR = 0.56, 95%CI 0.37-0.85, P = 0.006). The quality of evidence was high for NMSC, and moderate for squamous-cell carcinoma and basal-cell carcinoma. No evidence of publication bias was observed. CONCLUSION: High quality evidence suggests that Sirolimus-based immunosuppression decreases risk of non-melanoma skin cancer, and Sirolimus has an antitumoral effect among kidney-transplant recipients.


Subject(s)
Carcinoma, Basal Cell/prevention & control , Carcinoma, Squamous Cell/prevention & control , Immunosuppression Therapy/adverse effects , Immunosuppressive Agents/therapeutic use , Sirolimus/therapeutic use , Skin Neoplasms/prevention & control , Carcinoma, Basal Cell/etiology , Carcinoma, Squamous Cell/etiology , Humans , Kidney Transplantation/adverse effects , Skin Neoplasms/etiology
2.
Zhongguo Zhong Yao Za Zhi ; 30(16): 1246-8, 2005 Aug.
Article in Chinese | MEDLINE | ID: mdl-16245899

ABSTRACT

OBJECTIVE: To study the possibility of hyaluronic acid as densifier of Shuanguangliao eye-drops. METHOD: The factors related with hyaluronic acid s viscosity, such as pH-value and storing temperature, are tested in this experiment. At the same time, we checked the stimulation, stability of the densifier. RESULT: There was not effect on viscosity of pH-value and storing temperature. No stimulation on the eye was found after densified with hyaluronic acid. The viscosity properties of hyaluronic acid are stablile. CONCLUSION: The hyaliuronic acid added to Shuanghuanglian eye-drops are stabiliable and it can be applied in eye-drops. The increased viscosity is benefit to extend the residence time of drug in eye.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Drugs, Chinese Herbal/administration & dosage , Hyaluronic Acid , Ophthalmic Solutions/administration & dosage , Plants, Medicinal , Animals , Anti-Bacterial Agents/isolation & purification , Drug Carriers , Drug Combinations , Drugs, Chinese Herbal/isolation & purification , Eye/drug effects , Female , Hyaluronic Acid/pharmacology , Hyaluronic Acid/toxicity , Hydrogen-Ion Concentration , Male , Ophthalmic Solutions/isolation & purification , Plants, Medicinal/chemistry , Rabbits , Temperature , Viscosity/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...